meprobamate has been researched along with Chronic Kidney Failure in 1 studies
Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)
Excerpt | Relevance | Reference |
---|---|---|
" Due to many different pharmacokinetic properties, no perfect rules for dosage in acute or chronic hemodialysis exist." | 1.27 | Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis. ( Forycki, Z; Ibe, K; Martens, F; Thalhofer, S, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forycki, Z | 1 |
Martens, F | 1 |
Thalhofer, S | 1 |
Ibe, K | 1 |
1 other study available for meprobamate and Chronic Kidney Failure
Article | Year |
---|---|
Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis.
Topics: Acetaminophen; Acute Kidney Injury; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Benzodia | 1985 |